Latanoprost Bgr (Latanoprost)

Latanoprost is a prostaglandin analog that binds to FP receptors in the eye, stimulating remodeling of the extracellular matrix and increasing uveoscleral outflow of aqueous humor. This enhanced outflow reduces intra‑ocular pressure, addressing the primary cause of glaucoma progression.

The prescribed dose of Latanoprost Bgr is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but exact dosing and administration schedule must follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a favorable efficacy profile compared with beta‑blockers or carbonic anhydrase inhibitors. It is often preferred for its potency in lowering intra‑ocular pressure and convenient dosing schedule.

Latanoprost Bgr should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and avoid freezing to maintain product stability.

Latanoprost Bgr is administered as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to form a pocket, and place a single drop into the conjunctival sac of the prescribed eye(s) once daily, usually in the evening.

Serious risks include severe allergic reactions, ocular inflammation such as uveitis, paradoxical increase in intra‑ocular pressure, corneal edema, and rare cases of vision loss. Patients should seek immediate medical attention if they experience significant eye pain, redness, or sudden vision changes.

Latanoprost Bgr should be avoided in patients with active ocular infections, known hypersensitivity to prostaglandin analogs, or those using other prostaglandin eye drops concurrently. Individuals with a history of uveitis or severe ocular inflammation should use the medication only under close ophthalmic supervision.